CrossRef enabled

PAC Archives

Archive →

Pure Appl. Chem., 1971, Vol. 28, No. 4, pp. 665-680

http://dx.doi.org/10.1351/pac197128040665

Natural and artificial bleomycins: chemistry and antitumour activities

H. Umezawa

CrossRef Cited-by theme picture

CrossRef Cited-by Linking

  • Li Bin, Zheng Yan-Bo, Li Dian-Dong, Zhen Yong-Su: Preparation and Evaluation of a CD13/APN-Targeting and Hydrolase-Resistant Conjugate that Comprises Pingyangmycin and NGR Motif-Integrated Apoprotein. J. Pharm. Sci. 2014, 103, 1204. <http://dx.doi.org/10.1002/jps.23893>
  • Duerfeldt Adam S., Boger Dale L.: Total Syntheses of (−)-Pyrimidoblamic Acid and P-3A. J. Am. Chem. Soc. 2014, 136, 2119. <http://dx.doi.org/10.1021/ja412298c>
  • Dondoni Alessandro: Heterocycles in organic synthesis: thiazoles and triazoles as exemplar cases of synthetic auxiliaries. Org Biomol Chem 2010, 8, 3366. <http://dx.doi.org/10.1039/c002586k>
  • Miyazaki Isao, Okumura Hideo, Simizu Siro, Takahashi Yoshikazu, Kanoh  Naoki, Muraoka Yasuhiko, Nonomura Yoshiaki, Osada Hiroyuki: Structure-Affinity Relationship Study of Bleomycins and Shble Protein by Use of a Chemical Array. Chem Eur J of Chem Bio 2009, 10, 845. <http://dx.doi.org/10.1002/cbic.200800728>
  • Mashraqui Sabir H., Mistry Hitesh, Sundaram Subramanain: π-Aryl/heteroaryl conjugated coumarin-thiazoles: Synthesis, optical spectral and nonlinear optic properties. J Heterocyclic Chem 2006, 43, 917. <http://dx.doi.org/10.1002/jhet.5570430416>
  • Wang Huijie, Ramotar Dindial: Cellular resistance to bleomycin in Saccharomyces cerevisiae is not affected by changes in bleomycin hydrolase levels. Biochem Cell Biol 2002, 80, 789. <http://dx.doi.org/10.1139/o02-167>
  • Boger Dale L, Aquila Brian M, Tse Winston C, Searcey Mark: Synthesis and evaluation of a novel bleomycin A2 analogue: continuing assessment of the linker domain. Tetrahetron Lett 2000, 41, 9493. <http://dx.doi.org/10.1016/S0040-4039(00)01633-6>
  • Boger Dale L., Cai Hui: Bleomycin: Untersuchungen zu Synthese und Wirkungsmechanismus. Angew Chem 1999, 111, 470. <http://dx.doi.org/10.1002/(SICI)1521-3757(19990215)111:4<470::AID-ANGE470>3.0.CO;2-M>
  • Boger Dale L., Teramoto Shuji, Cai Hui: N-methyl threonine analogues of deglycobleomycin A2: Synthesis and evaluation. biorg med chem 1997, 5, 1577. <http://dx.doi.org/10.1016/S0968-0896(97)00107-7>
  • Boger Dale L., Teramoto Shuji, Cai Hui: Synthesis and evaluation of deglycobleomycin A2 analogues containing a tertiary N-methyl amide and simple ester replacement for the l-histidine secondary amide: Direct functional characterization of the requirement for secondary amide metal complexation. biorg med chem 1996, 4, 179. <http://dx.doi.org/10.1016/0968-0896(95)00183-2>
  • Cai Hui, Boger Dale L., Ramsey Timothy M.: Synthesis and evaluation of potential Nπ and Nσ metal chelation sites within the β-hydroxy-l-histidine subunit of bleomycin A2: Functional characterization of imidazole Nπ metal complexation. biorg med chem 1996, 4, 195. <http://dx.doi.org/10.1016/0968-0896(95)00184-0>
  • Kim Hong-Seok, Kwon Il-Cheon, Kim Oh-Hwoan: Synthesis of 2-Substituted-4-carbethoxythiazoles. J Heterocyclic Chem 1995, 32, 937. <http://dx.doi.org/10.1002/jhet.5570320344>
  • Benediktsson Indridi, Spampinato Claudia P., Schieder Otto: Studies of the mechanism of transgene integration into plant protoplasts: improvement of the transformation rate. EUPH 1995, 85, 53. <http://dx.doi.org/10.1007/BF00023930>
  • Boger Dale L., Colletti Steven L., Teramoto Shuji, Ramsey Timothy M., Zhou Jiacheng: Synthesis of key analogs of bleomycin A2 that permit a systematic evaluation of the linker region: Identification of an exceptionally prominent role for the l-threonine substituent. biorg med chem 1995, 3, 1281. <http://dx.doi.org/10.1016/0968-0896(95)00113-U>
  • Boger Dale L., Menezes Royce F., Honda Takeshi: Totalsynthese von (-)-Pyrimidoblamsäure und Deglycobleomycin A2. Angew Chem 1993, 105, 310. <http://dx.doi.org/10.1002/ange.19931050240>
  • Boger Dale L., Yang Wenjin: P-3A and (−)-desacetamido P-3A: demonstration and Study of their effective functional cleavage of duplex DNA. Biorg Med Chem Lett 1992, 2, 1649. <http://dx.doi.org/10.1016/S0960-894X(00)80449-7>
  • Boger Dale L., Menezes Royce F., Yang Wenjin: A simple method for the purification and isolation of bleomycin A2. Biorg Med Chem Lett 1992, 2, 959. <http://dx.doi.org/10.1016/S0960-894X(00)80597-1>
  • Boger Dale L., Menezes Royce F., Dang Qun, Yang Wenjin: Deglyco GABA-Gly-desacetamidobleomycin A2: a simplified synthetic model for bleomycin A2. Biorg Med Chem Lett 1992, 2, 261. <http://dx.doi.org/10.1016/S0960-894X(01)81076-3>
  • Datta K., Das S. K., Roy S. K.: A Rapid and Inexpensive Thin Layer Chromatographic Method for Quantitative Analysis of Bleomycin Complex. Journal of Liquid Chromatography 1989, 12, 949. <http://dx.doi.org/10.1080/01483918908051772>
  • Twentyman Peter R.: Bleomycin—mode of action with particular reference to the cell cycle. Pharmacol Ther 1983, 23, 417. <http://dx.doi.org/10.1016/0163-7258(83)90022-0>
  • Deriemer Leslie H., Meares Claude F., Goodwin David A., Diamanti Carol I.: Bledta II: Synthesis of a new tumor-visualizing derivative of CO(III)-bleomycin. J Lab Compds Radiopharm 1981, 18, 1517. <http://dx.doi.org/10.1002/jlcr.2580181017>
  • Gutteridge J.M.C., Shute Dawn J., Lightbown J.W., Moss-Blundell A.J., Bernstein S., Shepherd Wilma M., Langford D.T., Ferris R., Kelly A., Christiansen Gerd: Changes in the composition, antibacterial and DNA-damaging properties of bleomycin following storage at elevated temperatures. Journal of Biological Standardization 1981, 9, 439. <http://dx.doi.org/10.1016/S0092-1157(81)80035-2>
  • Kihara K., Ishida S., Okumura H., Lightbown J.W., Gutteridge J.M.C., Shute Dawn, Schaffer Frederick L., Soergel Marjorie E., Williams James E.: Detection of mycoplasmal contaminants in sera. Journal of Biological Standardization 1981, 9, 243. <http://dx.doi.org/10.1016/S0092-1157(81)80050-9>
  • Shiu Gerald K., Goehl Thomas J., Pitlick William H.: Rapid high-performance liquid chromatographic determination of bleomycin A2 in plasma. J Pharm Sci 1979, 68, 232. <http://dx.doi.org/10.1002/jps.2600680228>
  • Brabbs Sylvia, Warr J. R.: Isolation and characterization of bleomycin-resistant clones of CHO cells. Genet Res 1979, 34, 269. <http://dx.doi.org/10.1017/S0016672300019509>
  • Kimball R.F., Vig Baldev K., Lewis Roger: The relation of repair phenomena to mutation induction in bacteria. Mutation Research/Reviews in Genetic Toxicology 1978, 55, 85. <http://dx.doi.org/10.1016/0165-1110(78)90019-2>
  • Takeshita M., Horwitz S. B., Grollman A. P.: MECHANISM OF THE ANTIVIRAL ACTION OF BLEOMYCIN. Ann N Y Acad Sci 1977, 284, 367. <http://dx.doi.org/10.1111/j.1749-6632.1977.tb21973.x>
  • Samuels Melvin L., Holoye Paul Y., Johnson Douglas E.: Bleomycin combination chemotherapy in the management of testicular neoplasia. Cancer (Philad ) 1975, 36, 318. <http://dx.doi.org/10.1002/1097-0142(197508)36:2<318::AID-CNCR2820360205>3.0.CO;2-V>